TradingView
rmcnally11
Nov 24, 2023 4:13 PM

Low downside  Long

NASDAQ:BLUE1D
bluebird bio, Inc.NASDAQ

Description

⋅

Asymmetric upside here on a biotech stock that's been absolutely battered. Runway for pharmaceutical approvals are ripe and Dec 20 could launch this.
Fundamental AnalysisBeyond Technical Analysis
More